Superficial Femoral Artery Recanalization Using Fiber Optic RealShape Technology.
endovascular surgery
fiber optic technology
occlusion
radiation
recanalization
superficial femoral artery
three dimensional
Journal
Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208
Informations de publication
Date de publication:
20 Jul 2022
20 Jul 2022
Historique:
received:
08
06
2022
revised:
15
07
2022
accepted:
18
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
29
7
2022
Statut:
epublish
Résumé
Report of a successful case of endovascular recanalization of an occluded superficial femoral artery (SFA) using Fiber Optic RealShape (FORS) technology. A 79-year-old male was referred for evaluation of multiple ischemic pretibial ulcers of the right lower extremity. Computed tomography-angiography (CTA) imaging confirmed significant stenosis of the right common femoral artery (CFA) and an occlusion of the SFA from its origin to the Hunter's canal. The patient was treated with a hybrid surgical procedure: an endarterectomy of the CFA and SFA origin was performed combined with an endovascular recanalization of the occluded SFA using FORS technology. During recanalization, the FORS guidewire slowly twisted subintimally around the occluded lumen of the SFA, maintaining the created corkscrew shape after pre-dilation with the percutaneous transluminal angioplasty (PTA) balloon and subsequent stenting. FORS technology can be successfully used during recanalization of an occluded SFA without the use of fluoroscopy. The corkscrew shape formed during recanalization in this case was retained during PTA balloon pre-dilation and stenting; this potentially improves hemodynamics and thereby reduces the risk of in-stent restenosis. However, expanding patient series and longer follow-up data are needed to increase the understanding of the feasibility and effectiveness of using FORS in the treatment of peripheral arterial occlusive disease.
Identifiants
pubmed: 35888679
pii: medicina58070961
doi: 10.3390/medicina58070961
pmc: PMC9317753
pii:
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Philips Medical Systems Netherlands B.V.
ID : no grant number available
Références
Ann Biomed Eng. 2016 Feb;44(2):466-76
pubmed: 26467554
Ann Vasc Surg. 2018 Feb;47:104-113
pubmed: 28893700
Eur J Radiol. 1998 Oct;28(3):192-8
pubmed: 9881251
JACC Cardiovasc Interv. 2019 Mar 11;12(5):473-480
pubmed: 30846087
Sci Rep. 2021 Jan 15;11(1):1613
pubmed: 33452294
Eur J Vasc Endovasc Surg. 2016 Nov;52(5):674-680
pubmed: 27569450
Eur J Vasc Endovasc Surg. 2020 Jul;60(1):135-143
pubmed: 32312666
J Vasc Interv Radiol. 2018 Mar;29(3):353-366
pubmed: 29306599
Cardiovasc Intervent Radiol. 1990 Dec;13(6):357-63
pubmed: 2149672
Eur J Vasc Endovasc Surg. 2021 Feb;61(2):317-325
pubmed: 33262088
Biomech Model Mechanobiol. 2019 Dec;18(6):1883-1893
pubmed: 31197509
J Environ Radioact. 2018 Dec;192:32-47
pubmed: 29883875
J Endovasc Ther. 2021 Apr;28(2):236-245
pubmed: 33331207
J Vasc Surg. 2013 Dec;58(6):1556-62
pubmed: 23891487
Eur J Vasc Endovasc Surg. 2011 Mar;41(3):372-7
pubmed: 21147004
Ann Vasc Surg. 2016 May;33:167-72
pubmed: 26902938
J Vasc Surg. 2011 Jan;53(1 Suppl):35S-38S
pubmed: 20846817
Vasa. 2019 Mar;48(2):167-174
pubmed: 30322344